| Dr Kimberly Ann Haala, PHD, LP | |
|
1025 Marsh St, Mankato, MN 56001-4752 | |
| (507) 625-4031 | |
| Not Available |
| Full Name | Dr Kimberly Ann Haala |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 17 Years |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063675858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | LP4973 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southwest Minnesota Region | 4688585771 | 533 |
News Archive
Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.
eGlobalTech announced today that it has been awarded a prime contract with the Health Resources and Services Administration to support an enterprise-wide Call Center Study.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they're called, also raise the risk of potentially dangerous blood clots.
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.
eGlobalTech announced today that it has been awarded a prime contract with the Health Resources and Services Administration to support an enterprise-wide Call Center Study.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they're called, also raise the risk of potentially dangerous blood clots.
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Ann Haala, PHD, LP 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 625-4031 | Dr Kimberly Ann Haala, PHD, LP 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 625-4031 |
News Archive
Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.
eGlobalTech announced today that it has been awarded a prime contract with the Health Resources and Services Administration to support an enterprise-wide Call Center Study.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they're called, also raise the risk of potentially dangerous blood clots.
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
› Verified 3 days ago
Elizabeth Ann Quinby, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1028 Woodland Ave, Mankato, MN 56001 Phone: 319-493-8773 | |
Ms. Janice Mary Boyum, MSLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 710 South 2nd St., Mankato, MN 56001 Phone: 507-625-7660 Fax: 507-625-8998 | |
Dr. Theodore Surdy, PHD LP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1227 Caledonia St, Mankato, MN 56001 Phone: 507-388-8874 Fax: 507-685-4807 | |
Dr. Nancy Fenrick, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 600 Reed St, Suite 115, Mankato, MN 56001 Phone: 507-625-4060 Fax: 507-625-3915 | |
Rosean Bishop, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
David Earl Hildebrandt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 100 Martin Luther King Dr, Mankato, MN 56001 Phone: 507-385-6574 Fax: 507-385-6511 |